Loading stock data…
Loading stock data…
US$0.71
Get one email when SMNR crosses your level. Checked every 15 minutes during market hours.
▼ -0.01 (-0.70%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
37.5
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.65
Bullish momentumMACD above its signal line (-0.83).
50-day average
3.11
Price belowShort-term trend reference.
200-day average
7.91
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Semnur Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company dedicated to developing and commercializing innovative non-opioid pain management products for treating acute and chronic pain conditions. Its lead product candidate, SP-102, is a novel injectable corticosteroid gel formulation designed specifically for patients suffering from moderate to severe lumbosacral radicular pain, offering a targeted alternative to traditional opioid therapies. Headquartered in Palo Alto, Ca…
www.semnurpharma.com| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-29 | 0.74 | 0.92 | ✓ Beat |
| 2026-05-08 | 0.11 | 0.13 | ✓ Beat |
| 2026-04-30 | 2.03 | 2.68 | ✓ Beat |
| 2026-02-25 | 0.16 | 0.43 | ✓ Beat |
Companies in the same industry, via Finnhub